German guideline for diagnosis and treatment of multiple sclerosis - a survey focusing neurologists in daily practise.

Heesen, C; Mokry, C; Salmen, A; Hegen, H; Mäurer, M; Warnke, C; Gehring, K; Berthele, A; Meier, U (2022). German guideline for diagnosis and treatment of multiple sclerosis - a survey focusing neurologists in daily practise. Multiple Sclerosis and Related Disorders, 63, p. 103828. Elsevier 10.1016/j.msard.2022.103828

[img] Text
1-s2.0-S2211034822003406-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (459kB)

We performed a web-based survey among German-speaking neurologists to evaluate the acceptance of the 2021 German guideline in the diagnosis and treatment of multiple sclerosis. Based on 327 replies in total, the current survey largely reproduced the findings of an earlier, smaller survey on the prefinal consultation version of the guideline and confirmed high acceptance rates. Half of the participants were practising neurologists. Neurologists from MS centers with more than 500 patients per year (n=26) were more critical of the guideline. They reiterated some of the criticisms of the previous feedback, and, in particular, felt that safety aspects are overemphasized in the guideline, thereby superseding early aggressive therapy.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Salmen, Anke

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2211-0348

Publisher:

Elsevier

Language:

English

Submitter:

Pubmed Import

Date Deposited:

03 May 2022 11:45

Last Modified:

05 Dec 2022 16:19

Publisher DOI:

10.1016/j.msard.2022.103828

PubMed ID:

35490449

BORIS DOI:

10.48350/169705

URI:

https://boris.unibe.ch/id/eprint/169705

Actions (login required)

Edit item Edit item
Provide Feedback